We design state-of-the-art facilities
Welcome to ProLife
the company that promotes LIFE, through Life-Science services
Emerged from the vast knowledge possessed by the promoter, Ram Iyer, who's been in the Life-Science industry for over 3 decades, serving various areas of supply chain operations.
​
The company started its India operations in the year 2006, with an aim of serving the Life-Science industry in the core areas of Manufacturing, QA & Regulatory affairs and Business development in the UK/EU markets.
​
As a result of constant persuasion from the industry professionals, we added one more business vertical to our core services, that gave birth to our signature Pharma training program called PharmXceed.
Who We Are
Life-Science field has in it a major responsibility - to protect & sustain lives.
​
One of the main tributaries of this vast river, is the Pharmaceutical Industry.
​
This industry covers a wide spectrum ranging from service segment incl Clinics, Hospitals, Primary Healthcare centres, etc., research segment incl Clinical Research centres, CROs, Basic Chemical research centres, etc., and supply-chain segment incl APIs & Excipient manufacturers, Finished dosage manufacturers, Medical device manufacturers, wholesale distributors, retail pharmacies and so on.
​
At ProLife, we add value to the supply-chain segment.
​
Through thoughtfully crafted business verticals, ProLife covers the Finished Dosage Formulations wing of this segment that powers the Life-Science industry.
​
The company's promoter and his associates have more than 3 decades of experience in this dynamic industry.
Our Presence
We are based in Chennai, INIDA.
​
As part of expansion plans, we started our overseas operations in the UK under the name Eunaris, in the year 2016. Through Eunaris, we cater to our overseas clients based in the UK and the wider EEA.
​
So get on board, to realise your dreams come true, as it did for all our highly satisfied clients!
Stay informed
The European Falsified Medicines Directive (commonly known as FMD) [2011/62/EU] has been brought in, to address the issue of falsified medicines entering the legitimate medicines supply chain across Europe. Falsified medicines include those with little or no active ingredients, the wrong active ingredients, fake or tampered packaging, and those where products and/or packaging have been stolen for re-use or re-sale.
​
Under the Directive, all new packs of prescription medicines placed on the market in Europe from February 2019 onwards will have to bear two safety features: a unique identifier(UI) in the form of a 2D data matrix (barcode) and an anti-tamper device (ATD).
​
Need more awareness on this topic? Get in touch with us.
Stay ahead
Does your manufacturing facility have seamless expansion possibilities that can help minimising plant shut-down time?
Stay relevant
Are you aware of the recent amendments in the EU-GMP guidelines?
How the regulatory bodies do a "risk-based approach", while planning & scheduling the inspections?
ProLife Pharma Consultants is one of the leading Pharmaceutical consultancy companies in India and one of the very few companies that gets involved as part of the site team, during the time of regulatory inspections.